跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
12-d
首页
药物
12-d
12-d
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
3, 7-cembradien-2, 11, 12-triol-6-O-beta-D-glucoside as well as preparation method and application of 3, 7-cembradien-2, 11, 12-triol-6-O-beta-D-glucoside
申请人: CHINA TOBACCO GUANGDONG IND CO
优先权: 2025
CN
Use of hederagenin 3-O--L-rhamnopyranosyl(1-2)-[-D-glucopyranosyl(1-4)]--L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
申请人: KIM SONG-BAE
优先权: 2005
US
3 件公开
COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
申请人: IDEMITSU KOSAN CO
优先权: 2021
EP
Peyer's patch and/or M-cell targeting ligands
申请人: MERRION RES I LTD
优先权: 2002
US
Preparation method of salbutamol slow release preparation
申请人: LIU LI
优先权: 2017
CN
Preparation method of doxazosin sustained-release preparation
申请人: LIU LI
优先权: 2017
CN
Preparation method of verapamil hydrochloride sustained-release preparation
申请人: LIU LI
优先权: 2017
CN
Method for preparing aminophylline slow-release preparation
申请人: LIU LI
优先权: 2017
CN
药物
反馈